Ad clinical trials

Explore recruiting ad clinical trials.

Recruiting ad studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ad trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase II Trial Investigating the Effect of Valproic Acid in Women with Adenomyosis.

Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

Neoadjuvant pembrolizumab in high-risk thyroid cancers (NEPENTHE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Ignite)

Poland, Netherlands, Portugal, Germany, Slovakia, Italy +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI1284 in Patients with Psychosis Associated with Alzheimer’s Disease

Croatia, Czechia, Spain, Poland, Bulgaria, Slovakia +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients with Early Alzheimer’s Disease - ADVANCE

Poland, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective, randomized, non-treatment controlled, investigator-blinded, multicenter study on the prophylaxis of early childhood symptoms of atopic dermatitis in high-risk children by continuous continuous application of a moisturizing barrier-stabilizing skin cream

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ad trials by city

Ad in Toronto Ad in Vancouver Ad in Montreal Ad in Calgary Ad in Edmonton Ad in Ottawa Ad in Winnipeg Ad in Quebec City Ad in Hamilton Ad in Kitchener Ad in London Ad in Halifax Ad in New York Ad in Los Angeles Ad in Chicago Ad in Houston

Ad clinical trials

Recruiting ad studies right now

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

Open-Label Extension Protocol to SNK01-AD01 Study

Fisetin in Mild Alzheimer's Disease

Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

Improving Mental Health for Care Partners of Persons With AD/ADRD

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals

Also recruiting in Europe

Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase II Trial Investigating the Effect of Valproic Acid in Women with Adenomyosis.

Neoadjuvant pembrolizumab in high-risk thyroid cancers (NEPENTHE)

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Ignite)

A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI1284 in Patients with Psychosis Associated with Alzheimer’s Disease

A Phase 2b, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients with Early Alzheimer’s Disease - ADVANCE

Prospective, randomized, non-treatment controlled, investigator-blinded, multicenter study on the prophylaxis of early childhood symptoms of atopic dermatitis in high-risk children by continuous continuous application of a moisturizing barrier-stabilizing skin cream

Ad trials by city

Other conditions